Menu
Search
|

Menu

Close
X

ANI Pharmaceuticals Inc ANIP.OQ (NASDAQ Stock Exchange Global Market)

68.08 USD
+0.50 (+0.74%)
As of Jun 22
chart
Previous Close 67.58
Open 67.80
Volume 50,023
3m Avg Volume 37,435
Today’s High 68.15
Today’s Low 67.33
52 Week High 74.63
52 Week Low 42.26
Shares Outstanding (mil) 11.80
Market Capitalization (mil) 803.16
Forward P/E 59.09
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
46
FY17
177
FY16
129
FY15
76
EPS (USD)
FY18
0.191
FY17
1.059
FY16
0.339
FY15
1.323
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
59.09
34.14
Price to Sales (TTM)
vs sector
4.30
8.17
Price to Book (MRQ)
vs sector
4.45
4.30
Price to Cash Flow (TTM)
vs sector
18.75
22.70
Total Debt to Equity (MRQ)
vs sector
112.74
17.55
LT Debt to Equity (MRQ)
vs sector
110.62
13.12
Return on Investment (TTM)
vs sector
3.82
13.10
Return on Equity (TTM)
vs sector
7.63
15.09

EXECUTIVE LEADERSHIP

Robert Brown
Independent Chairman of the Board, Since 2013
Salary: --
Bonus: --
Arthur Przybyl
President, Chief Executive Officer, Director, Since 2013
Salary: $572,000.00
Bonus: $343,200.00
Stephen Carey
Chief Financial Officer, Vice President, Since 2016
Salary: $229,848.00
Bonus: $96,012.00
James Marken
Vice President - Operations, Since 2013
Salary: $315,067.00
Bonus: $117,339.00
Mark Ginski
Vice President of Corticotropin Product Development, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

210 W Main St
BAUDETTE   MN   56623-2467

Phone: +1218.6343500

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.

SPONSORED STORIES